Strict construction of exemption notifications governs intravenous fluid classification, with burden on assessee and remand for fresh consideration.

Intravenous fluids containing added medicinal ingredients were examined against Notification No. 3/2001 after a budget clarification appeared to confine the exemption to fluids used for sugar, electrolyte or fluid replenishment. The SC noted that the Tribunal had not considered the effect of that clarification and remitted the matter for fresh adjudication. The Court also left open whether the product's Schedule H character affected exemption eligibility, directing reconsideration with further evidence if needed. The governing principles stated were that exemption notifications must be construed strictly and that the assessee bears the burden of proving the goods fall squarely within the notification.

---

---

Issues: (i) Whether intravenous fluids with added medicinal ingredients continued to fall within Notification No. 3/2001 in view of the 2001-2002 Budget clarification restricting the exemption to fluids used for sugar, electrolyte or fluid replenishment; and (ii) whether the Schedule H character of the product had a bearing on eligibility for exemption.

Issue (i): Whether intravenous fluids with added medicinal ingredients continued to fall within Notification No. 3/2001 in view of the 2001-2002 Budget clarification restricting the exemption to fluids used for sugar, electrolyte or fluid replenishment.

Analysis: The exemption earlier available under Notifications No. 6/2000 and 36/2000 was subsequently narrowed by Notification No. 3/2001, and the Department relied on the budgetary explanation to contend that only intravenous fluids used for sugar, electrolyte or fluid replenishment remained exempt. The Tribunal had not examined the effect of that clarification.

Conclusion: The matter was remitted for fresh consideration on this issue.

Issue (ii): Whether the Schedule H character of the product had a bearing on eligibility for exemption.

Analysis: The product labels described the fluid as a Schedule H drug, and the Department relied on the Drugs and Cosmetics Rules, 1945 and Schedule H to contend that a product having dominant therapeutic value would fall outside the exemption. No final opinion was expressed on this question, and the Tribunal was directed to consider it afresh, including the need for further evidence if required.

Conclusion: The question was left for reconsideration on remand.

Final Conclusion: The Department's appeals succeeded, the impugned decision was set aside, and the matters were sent back for fresh adjudication in accordance with law, with the governing principles that exemption notifications are to be construed strictly and the burden lies on the assessee to establish coverage.

Ratio Decidendi: Exemption notifications must be construed strictly, and the assessee bears the burden of proving that the goods fall squarely within the notification; where a material aspect affecting exemption has not been examined, remand for fresh consideration is appropriate.

---